2Ikeda E, Shiba K, Mori H, et al. Reduction of acetylcholine transporter in β-amyloid protein-infused rats with memory impairment. Nucl Med Commun, 2000, 21(10):933-937
3Boncristiano S, Calhoun ME, Kelly PH, et al. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis. J Neurosci, 2002, 22(8):3234-3243
4Shi J, Schulze S, Lardy H. The effect of 7-oxo-DHEA acetate on memory in young and old C57B/6 mice.Steroids, 2000, 65(3):124-129
5Song X, Bao M, Li D, et al. Advanced glycation in D-galactose induced mouse aging model. Mech ageing Dev,1999, 108(3):239-251
6Shinotoh H, Namba H, Fukushi K, et al. Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's Disease: a positron emission tomography study. Ann Neurol, 2000, 48(2):194-200
7Yoshida T, Kuwabara Y, Ichiya Y, et al. Cerebral muscarinic acetylcholinergic receptor measurement in Alzheimer's disease patients on 11 C-N-methy-4-piperidyl benzilate-comparison with cerebral blood flow and cerebral glucose metabolism.Ann Nucl Med, 1998, 12(1):35-42
8Wang R, Zhang HY, Tang XC. Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by β-amyloid protein-(1-40) in rat. Eur J Pharmacol, 2001,421 (3): 149-156
